Opioid pharmacology post: Other Resources Dynamed – Opioids for... | Nursing

Clinical Requirement:

Other Resources Dynamed – Opioids for chronic pain: https://wilkes.idm.oclc.org/login?url=https://www-dynamed-com.wilkes.idm.oclc.org/management/opioids-for-chronic-noncancer-pain Dynamed- Chronic low back pain: https://wilkes.idm.oclc.org/login?url=https://www-dynamed-com.wilkes.idm.oclc.org/condition/chronic-low-back-pain Dynamed- Osteoarthritis of the hip: https://wilkes.idm.oclc.org/login?url=https://www-dynamed-com.wilkes.idm.oclc.org/condition/osteoarthritis-oa-of-the-hip Dynamed – Osteoarthritis of the knee: https://wilkes.idm.oclc.org/login?url=https://www-dynamed-com.wilkes.idm.oclc.org/condition/osteoarthritis-oa-of-the-knee Dynamed – Peripheral neuropathy: https://wilkes.idm.oclc.org/login?url=https://www-dynamed-com.wilkes.idm.oclc.org/condition/peripheral-neuropathy Dynamed – Opioid abuse and dependence: https://wilkes.idm.oclc.org/login?url=https://www-dynamed-com.wilkes.idm.oclc.org/condition/opioid-abuse-and-dependence Nociceptive and neuropathic pain: https://www-proquest-com.wilkes.idm.oclc.org/docview/2000726586?pq-origsite=360link SUBOXONE® (buprenorphine and naloxone)  Prescribing information: https://www.suboxone.com/pdfs/prescribing-information.pdf Evidence Based Practice Guidelines Chou, R., et al. (2009). American Pain Society: Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. The Journal of Pain, Vol 10, No 2 (February), 2009: pp 113-130. https://www.jpain.org/article/S1526-5900(08)00831-6/pdf Dowell, D., Haegerich, T. M., Chou, R. (2016). CDC: Guideline for Prescribing Opioids for Chronic Pain. Recommendations and Reports. Morbidity and Mortality Weekly Reports. March 18, 2016 / 65(1);1–49. https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm?s_cid=rr6501e1_w Manchikanti, L., et al. (2017) ASIPP: Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain. Pain Physician. 2017 Feb;20(2S):S3-S92. http://www.painphysicianjournal.com/current/pdf?article=NDIwMg%3D%3D&journal=103 Ferrell, B., et.al. (2009) American Geriatric Society: Guideline on pharmacological management of persistent pain in older persons. Journal of American Geriatric Society,  2009 Aug;57(8):1331-46. http://pubmed.ncbi.nlm.nih.gov/19573219?dopt=Abstract Patient rounds involve various disciplines coming together to discuss the patient’s condition and coordinate care. They are used as an educational tool and also help keep everyone on the same page when it comes to the treatment plan. The following case is found in the textbook (Pharmacotherapy: Principles and Practices. Chisholm-Burns et al, eds.  6th edition.  McGraw-Hill.  New York 2022. ISBN: 978-1-260-46027-8; Chapter 35. "Patient encounter"). After reading the assigned chapters in the textbook, resources identified in Dynamed and Evidence based practice guidelines, please present the case to your peers in the form of a discussion. This will be your initial post. Please be sure to address all parts of the case and ensure your responses are well researched [including supporting, evidence based guidelines such those of the WHO, CDC, APS, etc.]. It is recommended this be complete between weeks 4-6. Your response post(s), to at least one peer, shall be based upon your research and references citing circumstances where you may either endorse or refute the information your peer has presented in their case workup.  The response post(s) must be completed by week 12 Part 3: She was discharged to a skilled nursing facility and is receiving physical therapy and occupational therapy 6 days each week. Current Meds: Metoprolol succinate ER 50 mg daily; rivaroxaban 20 mg daily; levothyroxine 150 mcg daily; polyethylene glycol 3350 17 g daily; lisinopril 2.5 mg daily; amiodarone 200 mg daily; sertraline 50 mg daily, hydrocodone/acetaminophen 10/325 mg every 6 hours as needed for pain. Pain Assessment: Patient reports pain of 7 out of 10; worse with movement. She complains of pain “everywhere, but my shoulder is really bothering me.” Physical therapy notes indicate patient is unable to complete therapy goals due to complaints of pain in her shoulder. Based on this information, what would you recommend to optimize pain control? Prescribers play a critical role in prescription drug misuse and abuse prevention. What steps can be taken to identify signs of dependence and abuse and what education can you provide to the patient regarding the negative effects of medication misuse? Part 4: The patient has been at the skilled nursing facility for 2 weeks and is making progress toward rehabilitation goals; however, during a follow-up appointment to her surgeon, she learned that she has metastatic ovarian cancer. She states that she has not been sleeping well and has lost 7 lb (3.2 kg) since admission. She also states that she hates waiting for her pain pills and requests something longer acting. Pain Assessment: 8 out of 10 Current Meds: Metoprolol succinate ER 50 mg daily; rivaroxaban 20 mg daily; levothyroxine 150 mcg daily; polyethylene glycol 3350 17 g daily; lisinopril 2.5 mg daily; amiodarone 200 mg daily; sertraline 50 mg daily; diclofenac transdermal gel 1% to neck and left shoulder four times daily; hydrocodone/acetaminophen 10/325 mg every 4 hours as needed for pain (uses 6 doses per day). What additional recommendations would you have at this time regarding pain management? Are there any other therapeutic issues that should be addressed? Part 5: The patient was discharged to her home, but 3 months after discharge was admitted to hospice service. She is no longer able to swallow her tablets and requires them to be crushed. The hospice nurse requests your advice on an equivalent regimen using transdermal fentanyl and oxycodone for breakthrough pain. Pain Assessment: 8 out of 10 Current Meds: Metoprolol succinate ER 50 mg daily; rivaroxaban 20 mg daily; levothyroxine 150 mcg daily; polyethylene glycol 3350 17 g daily; lisinopril 2.5 mg daily; amiodarone 200 mg daily; diclofenac transdermal gel 1% to neck and left shoulder four times daily; morphine sulfate ER 30 mg twice daily; mirtazapine 15 mg at bedtime. What additional recommendations would you have at this time regarding pain management? Are there any other therapeutic issues that should be addressed?